Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers

British Journal of Cancer

Volumn 105, Issue 8, 2011, Pages 1203-1209

  Shao, R ^a,b   Cao, Q J ^c   Arenas, R B ^d   Bigelow, C ^b   Bentley, B ^a   Yan, W ^a  

^a Pioneer Valley Life Sciences Institute   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c TUFTS UNIVERSITY   (United States)

^d BAYSTATE MEDICAL CENTER   (United States)

Author keywords

breast cancer biomarker; breast ductal carcinoma in situ; clinical outcome; invasive ductal carcinoma; YKL 40

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG; UVOMORULIN; YKL 40 PROTEIN;

ADULT; ARTICLE; BREAST CARCINOMA; BREAST RECONSTRUCTION; CANCER GRADING; CANCER INVASION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

ADIPOKINES; ADULT; ANTIBODY SPECIFICITY; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL DIFFERENTIATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LECTINS; MIDDLE AGED; PARAFFIN EMBEDDING; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 80053970009     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.347     Document Type: Article

References (45)

1. Badariotti F, Kypriotou M, Lelong C, Dubos MP, Renard E, Galera P, Favrel P (2006) The phylogenetically conserved molluscan chitinase-like protein 1 (Cg-Clp1), homologue of human HC-gp39, stimulates proliferation and regulates synthesis of extracellular matrix components of mammalian chondrocytes. J Biol Chem 281: 29583-29596 (Pubitemid 44536966)
2. Bergmann OJ, Johansen JS, Klausen TW, Mylin AK, Kristensen JS, Kjeldsen E, Johnsen HE (2005) High serum concentration of YKL-40 is associated with short survival in patients with acute myeloid leukemia. Clin Cancer Res 11: 8644-8652 (Pubitemid 43005912)
3. Bertucci F, Houlgatte R, Benziane A, Granjeaud S, Adelaide J, Tagett R, Loriod B, Jacquemier J, Viens P, Jordan B, Birnbaum D, Nguyen C (2000) Gene expression profiling of primary breast carcinomas using arrays of candidate genes. Hum Mol Genet 9: 2981-2991 (Pubitemid 32000771)
4. Bigg HF, Wait R, Rowan AD, Cawston TE (2006) The mammalian chitinase-like lectin, YKL-40, binds specifically to type I collagen and modulates the rate of type I collagen fibril formation. J Biol Chem 281: 21082-21095 (Pubitemid 44115449)
5. Blackman DJ, Masi CM (2006) Racial and ethnic disparities in breast cancer mortality: are we doing enough to address the root causes? J Clin Oncol 24: 2170-2178 (Pubitemid 46655602)
6. Chang HR (2010) Trastuzumab-based neoadjuvant therapy in patients with HER2-positive breast cancer. Cancer 116: 2856-2867
7. Cheng CW, Wu PE, Yu JC, Huang CS, Yue CT, Wu CW, Shen CY (2001) Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene. Oncogene 20: 3814-3823
8. Cintin C, Johansen JS, Christensen IJ, Price PA, Sorensen S, Nielsen HJ (1999) Serum YKL-40 and colorectal cancer. Br J Cancer 79: 1494-1499 (Pubitemid 29116810)
9. Cintin C, Johansen JS, Christensen IJ, Price PA, Sorensen S, Nielsen HJ (2002) High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival. Cancer 95: 267-274 (Pubitemid 34787591)
10. De Ceuninck F, Gaufillier S, Bonnaud A, Sabatini M, Lesur C, Pastoureau P (2001) YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem Biophys Res Commun 285: 926-931 (Pubitemid 32918025)
11. Eeckhoute J, Keeton EK, Lupien M, Krum SA, Carroll JS, Brown M (2007) Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. Cancer Res 67: 6477-6483 (Pubitemid 47037533)
12. Francescone RA, Scully S, Faibish M, Taylor SL, Oh D, Moral L, Yan W, Bentley B, Shao R (2011) Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma. J Biol Chem 286: 15332-15343
13. Fusetti F, Pijning T, Kalk KH, Bos E, Dijkstra BW (2003) Crystal structure and carbohydrate-binding properties of the human cartilage glycopro-tein-39. J Biol Chem 278: 37753-37760 (Pubitemid 37175301)
14. Garcia-Closas M, Troester MA, Qi Y, Langerod A, Yeager M, Lissowska J, Brinton L, Welch R, Peplonska B, Gerhard DS, Gram IT, Kristensen V, Borresen-Dale AL, Chanock S, Perou CM (2007) Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status. Cancer Epidemiol Biomarkers Prev 16: 2269-2275 (Pubitemid 351196359)
15. Graff JR, Gabrielson E, Fujii H, Baylin SB, Herman JG (2000) Methylation patterns of the E-cadherin 50 CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 275: 2727-2732 (Pubitemid 30082043)
16. Hakala BE, White C, Recklies AD (1993) Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 268: 25803-25810 (Pubitemid 23358198)
17. Hogdall EV, Johansen JS, Kjaer SK, Price PA, Christensen L, Blaakaer J, Bock JE, Glud E, Hogdall CK (2003) High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival. Oncol Rep 10: 1535-1538
18. Hu B, Trinh K, Figueira WF, Price PA (1996) Isolation and sequence of a novel human chondrocyte protein related to mammalian members of the chitinase protein family. J Biol Chem 271: 19415-19420 (Pubitemid 26271614)
19. Jatoi I, Miller AB (2003) Why is breast-cancer mortality declining? Lancet Oncol 4: 251-254 (Pubitemid 36503323)
20. Jensen BV, Johansen JS, Price PA (2003) High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer. Clin Cancer Res 9: 4423-4434 (Pubitemid 37248400)
21. Johansen JS, Christensen IJ, Riisbro R, Greenall M, Han C, Price PA, Smith K, Brunner N, Harris AL (2003) High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival. Breast Cancer Res Treat 80: 15-21 (Pubitemid 36851281)
22. Johansen JS, Cintin C, Jorgensen M, Kamby C, Price PA (1995) Serum YKL-40: a new potential marker of prognosis and location of metastases of patients with recurrent breast cancer. Eur J Cancer 31A: 1437-1442
23. Junttila TT, Parsons K, Olsson C, Lu Y, Xin Y, Theriault J, Crocker L, Pabonan O, Baginski T, Meng G, Totpal K, Kelley RF, Sliwkowski MX (2010) Superior in vivo efficacy of afucosylated trastuzumab in the treatment of HER2-amplified breast cancer. Cancer Res 70: 4481-4489
24. Kim SH, Das K, Noreen S, Coffman F, Hameed M (2007) Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer. World J Surg Oncol 5: 17
25. Ko LJ, Engel JD (1993) DNA-binding specificities of the GATA transcription factor family. Mol Cell Biol 13: 4011-4022 (Pubitemid 23187629)
26. Kouros-Mehr H, Bechis SK, Slorach EM, Littlepage LE, Egeblad M, Ewald AJ, Pai SY, Ho IC, Werb Z (2008a) GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell 13: 141-152 (Pubitemid 351163164)
27. Kouros-Mehr H, Kim JW, Bechis SK, Werb Z (2008b) GATA-3 and the regulation of the mammary luminal cell fate. Curr Opin Cell Biol 20: 164-170
28. Kucur M, Isman FK, Balci C, Onal B, Hacibekiroglu M, Ozkan F, Ozkan A (2008) Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia. Urol Oncol 26: 47-52
29. Kzhyshkowska J, Gratchev A, Goerdt S (2007) Human chitinases and chitinase-like proteins as indicators for inflammation and cancer. Biomark Insights 2: 128-146
30. Lian Z, De Luca P, Di Cristofano A (2006) Gene expression analysis reveals a signature of estrogen receptor activation upon loss of Pten in a mouse model of endometrial cancer. J Cell Physiol 208: 255-266 (Pubitemid 43993415)
31. Mehra R, Varambally S, Ding L, Shen R, Sabel MS, Ghosh D, Chinnaiyan AM, Kleer CG (2005) Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. Cancer Res 65: 11259-11264 (Pubitemid 41821679)
32. Mohanty AK, Singh G, Paramasivam M, Saravanan K, Jabeen T, Sharma S, Yadav S, Kaur P, Kumar P, Srinivasan A, Singh TP (2003) Crystal structure of a novel regulatory 40-kDa mammary gland protein (MGP-40) secreted during involution. J Biol Chem 278: 14451-14460 (Pubitemid 36799998)
33. Nyirkos P, Golds EE (1990) Human synovial cells secrete a 39kDa protein similar to a bovine mammary protein expressed during the non-lactating period. Biochem J 269: 265-268 (Pubitemid 20210872)
34. Pelloski CE, Mahajan A, Maor M, Chang EL, Woo S, Gilbert M, Colman H, Yang H, Ledoux A, Blair H, Passe S, Jenkins RB, Aldape KD (2005) YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma. Clin Cancer Res 11: 3326-3334 (Pubitemid 40627883)
35. Recklies AD, White C, Ling H (2002) The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase-and protein kinase B-mediated signalling pathways. Biochem J 365: 119-126 (Pubitemid 34756146)
36. Rehli M, Krause SW, Andreesen R (1997) Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics 43: 221-225 (Pubitemid 27335226)
37. Rejman JJ, Hurley WL (1988) Isolation and characterization of a novel 39 kilodalton whey protein from bovine mammary secretions collected during the nonlactating period. Biochem Biophys Res Commun 150: 329-334 (Pubitemid 18036240)
38. Renkema GH, Boot RG, Au FL, Donker-Koopman WE, Strijland A, Muijsers AO, Hrebicek M, Aerts JM (1998) Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages. Eur J Biochem 251: 504-509 (Pubitemid 28080953)
39. Roslind A, Knoop AS, Jensen MB, Johansen JS, Nielsen DL, Price PA, Balslev E (2007) YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer. Breast Cancer Res Treat 112: 275-285
40. Shackelton LM, Mann DM, Millis AJ (1995) Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling. J Biol Chem 270: 13076-13083
41. Shao R, Hamel K, Petersen L, Cao QJ, Arenas RB, Bigelow C, Bentley B, Yan W (2009) YKL-40, a secreted glycoprotein, promotes tumor angiogenesis. Oncogene 28: 4456-4468
42. Voduc D, Cheang M, Nielsen T (2008) GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value. Cancer Epidemiol Biomarkers Prev 17: 365-373 (Pubitemid 351272788)
43. Willsher PC, Beaver J, Pinder S, Bell JA, Ellis IO, Blamey RW, Robertson JF (1996) Prognostic significance of serum c-erbB-2 protein in breast cancer patients. Breast Cancer Res Treat 40: 251-255 (Pubitemid 26336120)
44. Wong AS, Gumbiner BM (2003) Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin. J Cell Biol 161: 1191-1203 (Pubitemid 36870179)
45. Yan W, Cao QJ, Arenas RB, Bentley B, Shao R (2010) GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition. J Biol Chem 285: 14042-14051